Leadership & Strategy at Orchestra BioMed Holdings, Inc. (OBIO)

Add OBIO to watchlist(s)

You Should Create a Watchlist In The First Place.

Price Over Time

Profile

Company Name

Orchestra BioMed Holdings, Inc.

Symbol

OBIO

Currency

USD

Exchange

Nasdaq

Head Quarter

United States, New Hope

Sector

Healthcare

Industry

Biotechnology

Website

https://orchestrabiomed.com

ISIN

US68572M1062

CIK

-

CUSIP

68572M106

UEI

-

LEI

-

Business Description

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease.